Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong
Errataetall: |
ErratumIn: J Clin Virol. 2022 Nov;156:105129. - PMID 35339381 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:148 |
---|---|
Enthalten in: |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 148(2022) vom: 01. März, Seite 105081 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tsang, Alan Kl [VerfasserIn] |
---|
Links: |
---|
Themen: |
B.1.1.529 |
---|
Anmerkungen: |
Date Completed 15.03.2022 Date Revised 21.12.2022 published: Print-Electronic ErratumIn: J Clin Virol. 2022 Nov;156:105129. - PMID 35339381 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jcv.2022.105081 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336255489 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336255489 | ||
003 | DE-627 | ||
005 | 20231225231726.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jcv.2022.105081 |2 doi | |
028 | 5 | 2 | |a pubmed24n1120.xml |
035 | |a (DE-627)NLM336255489 | ||
035 | |a (NLM)35091227 | ||
035 | |a (PII)S1386-6532(22)00017-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tsang, Alan Kl |e verfasserin |4 aut | |
245 | 1 | 0 | |a Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.03.2022 | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumIn: J Clin Virol. 2022 Nov;156:105129. - PMID 35339381 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a B.1.1.529 | |
650 | 4 | |a Hong Kong SAR | |
650 | 4 | |a Omicron | |
650 | 4 | |a SARS-CoV-2 | |
650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
700 | 1 | |a Cheng, Peter Kc |e verfasserin |4 aut | |
700 | 1 | |a Mak, Gannon Ck |e verfasserin |4 aut | |
700 | 1 | |a Leung, Patricia Kl |e verfasserin |4 aut | |
700 | 1 | |a Yip, Peter Cw |e verfasserin |4 aut | |
700 | 1 | |a Lam, Edman Tk |e verfasserin |4 aut | |
700 | 1 | |a Ng, Ken Hl |e verfasserin |4 aut | |
700 | 1 | |a Chan, Rickjason Cw |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology |d 1997 |g 148(2022) vom: 01. März, Seite 105081 |w (DE-627)NLM097223964 |x 1873-5967 |7 nnns |
773 | 1 | 8 | |g volume:148 |g year:2022 |g day:01 |g month:03 |g pages:105081 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcv.2022.105081 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 148 |j 2022 |b 01 |c 03 |h 105081 |